Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 11, 2014New England Journal of MedicineOpen Access

Adjuvant Ovarian Suppression in Premenopausal Breast Cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

PFPrudence A. FrancisMRMeredith M. ReganHarvard UniversityGFGini F. FlemingUniversity of Chicago

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Francis et al. (2014) studied this question.

synapsesocial.com/papers/693dfe9e35a649d042a9a141https://doi.org/10.1056/nejmoa1412379
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen2009 · 818 citations
  2. 2Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer2014 · 757 citations